Nomura Holdings Inc Lantheus Holdings, Inc. Transaction History

Nomura Holdings Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$58.87 - $83.05 $85,126 - $120,090	1,446 Added 30.69%	6,158 $494,000
Q1 2024 May 15, 2024	BUY	$51.07 - $68.26 $240,641 - $321,641	4,712 New	4,712 $293,000
Q4 2023 Feb 14, 2024	BUY	$55.6 - $77.89 $417,389 - $584,720	7,507 Added 57.0%	20,678 $1.28 Million
Q3 2023 Nov 14, 2023	SELL	$60.27 - $90.75 $399,529 - $601,581	-6,629 Reduced 33.48%	13,171 $915,000
Q2 2023 Aug 14, 2023	BUY	$82.41 - $99.65 $1.63 Million - $1.97 Million	19,800 New	19,800 $1.66 Million

542

68M

679K

423K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $6.29B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

Stay updated on Nomura Holdings Inc with notifications on news.